Synopsis
Section I: Diagnosis and Characterization of Brain Tumors.- MR perfusion imaging-ASL, T2* DSC and T1 DCE methods.- Diffusion Tensor Imaging.- Molecular imaging.- Role of PET in Neuro-Oncology.- MR Spectroscopic Imaging.- Section II: Physiologic Imaging for Planning and Monitoring of Therapeutic Intervention.- BOLD fMRI for Pre-surgical Planning.- BOLD fMRI for Pre-surgical Planning.- DTI for Pre-surgical Planning.- MSI/MEG for Pre-surgical Planning.- Role of BOLD and DTI in Radiation Therapy Planning.- BOLD and DTI Assessment of Brain Plasticity.- MR Perfusion Imaging for Monitoring Treatment Response.- MR Spectroscopic Imaging Role in Assessing Tumor Progression vs. Treatment Effects.- PET Role in Assessing Tumor Progression vs. Treatment Effects.- Role of MRSI and PET in Assessing Therapeutic Response.- Section III: Future Directions in Physiologic Brain Tumor Imaging.- Role of Novel MR Perfusion Sequences in Brain Tumor Imaging-VASO, iVASO, APT.- Evolving Role of BOLD Imaging in Monitoring Therapeutic Intervention.- Advanced Diffusion Imaging-HARDI, DSI, New Approaches to Fiber Tracking.- Ultra-High Field Diffusion Imaging.- Ultra-High Field MRSI.- Ultra-High Field Non-Proton Magnetic Resonance Imaging, including Sodium Imaging.- Future Clinical Applications of Molecular Imaging-Nanoparticles, Cellular Probes, Imaging of Gene Expression.- Future Role of MSI/MEG in Brain Tumor Research.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
